News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point

Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Today on Medscape
Business of Medicine
Medical Lifestyle
Science & Technology
Medical Students
Nurses
Pharmacists
Residents
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      Friday, September 29, 2023
      News & Perspective Drugs & Diseases CME & Education Academy Video Decision Point

      From Medscape Psychiatry

      Coverage from the

      29th European College of Neuropsychopharmacology (ECNP) Congress

      September 17 - 20, 2016; Vienna, Austria

      September 17 - 20, 2016 Vienna, Austria

      Conference News

      Popular News from ECNP 2015

      • Test Predicts Drug Response in Depression, Anxiety Test Predicts Drug Response in Depression, Anxiety Pharmacogenomic testing predicts patient response to psychotropic medications and enhances treatment outcomes by identifying the best drug for individual patients, a new study suggests.
        Medscape Medical News, Sep 4, 2015
      • Novel Drug First to Treat Negative Symptoms in Schizophrenia Novel Drug First to Treat Negative Symptoms in Schizophrenia A novel antipsychotic that treats predominant persistent negative symptoms in schizophrenia, as well as positive symptoms, is significantly more effective than standard antipsychotic therapy.
        Medscape Medical News, Sep 9, 2015
      • PRIDE Continues to Support ECT in Depressed Elderly PRIDE Continues to Support ECT in Depressed Elderly Updated findings from the PRIDE trial continue to support right unilateral electrode placement and ultrabrief pulse ECT to achieve robust and rapid response in geriatric major depressive disorder.
        Medscape Medical News, Aug 30, 2015

      Medscape Psychiatry©  WebMD, LLC

      Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

      ECNP on Twitter

      Find Us On
      About
      About Medscape Privacy Policy Editorial Policy Cookies Terms of Use Advertising Policy Help Center
      Membership
      Become a Member About You Professional Information Newsletters & Alerts Market Research
      App
      Medscape
      WebMD Network
      Medscape Live Events WebMD MedicineNet eMedicineHealth RxList WebMD Corporate Medscape UK
      Editions
      English Deutsch Español Français Português UK
      All material on this website is protected by copyright, Copyright © 1994-2023 by WebMD LLC. This website also contains material copyrighted by 3rd parties.